Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.58 |
| ▸ | CNR2 | P34972 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | XBP1 | P17861 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20399514 | 0.89 | ALDH1A1 (0.51) | ALDH1A1TSHRKDM4EKMT2ATAAR1 | |
| SCHEMBL20399450 | 0.88 | KAT8 (0.53) | ALDH1A1TSHRKDM4E | |
| SCHEMBL12788915 | 0.87 | TSHR (0.69) | ALDH1A1TSHRKDM4EKMT2ATAAR1 | |
| SCHEMBL6809980 | 0.87 | ALDH1A1 (0.55) | ALDH1A1TSHRKDM4EKMT2ATAAR1 | |
| SCHEMBL10757759 | 0.86 | ALDH1A1 (0.51) | ALDH1A1TSHRKDM4EKMT2ATAAR1 | |
| SCHEMBL18328794 | 0.86 | ALDH1A1 (0.51) | ALDH1A1TSHRKDM4EKMT2ATAAR1 | |
| SCHEMBL27935838 | 0.86 | ALDH1A1 (0.51) | ALDH1A1TSHRKDM4EKMT2ATAAR1 | |
| SCHEMBL532205 | 0.85 | CNR1 (0.53) | CNR1CNR2TSHRKDM4EKMT2A | |
| SCHEMBL10762625 | 0.85 | TRPA1 (0.57) | ALDH1A1TSHRKDM4EKMT2ATAAR1 | |
| SCHEMBL586875 | 0.83 | ALDH1A1 (0.55) | ALDH1A1TSHRKDM4EKMT2ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3303276-B1 | PRODUCTION OF 3-ALKYLPHENOLS | UNIV LEUVEN KATH (BE) | 2023-04-12 | — | — | EP | claimed |
| EP-4103576-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | Glycoscience, S.L. (ES) | 2022-12-21 | — | — | EP | claimed |
| WO-2021160670-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | GLYCOSCIENCE, S.L. (ES) | 2021-08-19 | — | — | WO | claimed |
| EP-3571180-B1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | UNIV LEUVEN KATH (BE) | 2024-12-18 | — | — | EP | disclosed |
| EP-3303276-B1 | PRODUCTION OF 3-ALKYLPHENOLS | UNIV LEUVEN KATH (BE) | 2023-04-12 | — | — | EP | disclosed |
| US-20210070684-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2021-03-11 | — | — | US | disclosed |
| US-10869822-B2 | Compositions for treatment of dermatological diseases and conditions and methods of use thereof | DermaMedics, LLC (US) | 2020-12-22 | — | — | US | disclosed |
| EP-3571180-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | Katholieke Universiteit Leuven (BE) | 2019-11-27 | — | — | EP | disclosed |
| US-20180235859-A1 | Compositions for Treatment of Dermatological Diseases and Conditions and Methods of Use Thereof | DermaMedics, LLC | 2018-08-23 | — | — | US | disclosed |
| WO-2018134427-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2018-07-26 | — | — | WO | disclosed |
| US-9980887-B2 | Compositions for use in treatment of hyperpigmentation and methods of use thereof | DermaMedics, LLC (US) | 2018-05-29 | — | — | US | disclosed |
| US-20120065185-A1 | SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE | AMGEN INC. (US) | 2012-03-15 | — | — | US | disclosed |
| US-8058445-B2 | Substituted pyridinecarboxamides for the treatment of cancer | AMGEN INC. (US) | 2011-11-15 | — | — | US | disclosed |
| US-20110046160-A1 | Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases | PFIZER, INC. | 2011-02-24 | — | — | US | disclosed |
| US-20100298369-A1 | BERBAMINE DERIVATIVES | CITY OF HOPE | 2010-11-25 | — | — | US | disclosed |
| EP-2244690-A1 | METHODS AND COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS | Therametics, Llc (US) | 2010-11-03 | — | — | EP | disclosed |
| US-20100249244-A1 | METHODS AND COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS | THERAMETICS, LLC | 2010-09-30 | — | — | US | disclosed |
| US-7687643-B2 | Process for preparing 3,3-dimethylindolines | AMGEN INC. (US) | 2010-03-30 | — | — | US | disclosed |
| US-7687643-B2 | Process for preparing 3,3-dimethylindolines | AMGEN INC. (US) | 2010-03-30 | — | — | US | disclosed |
| WO-2009049172-A1 | METHODS AND COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS | THERAMETICS, LLC (US) | 2009-04-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298369-A1 | BERBAMINE DERIVATIVES | BAK1, MCL1, BAD | CNR1 2649/4885CNR2 2986/4885ALDH1A1 1755/4885 |
| US-20210070684-A1 | PRODUCTION OF HIGHLY PURE META,META-COUPLED BIS(4-ALKYLPHENOL) DERIVATIVES AND USES THEREOF | MMS19, PCBP1, PBRM1 | CNR1 1840/4885CNR2 1956/4885ALDH1A1 1877/4885 |
| US-20120065185-A1 | SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE | AADAC, NAT1, PIGO | CNR1 46/4885CNR2 22/4885ALDH1A1 327/4885 |
| US-20110046160-A1 | Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases | SNCA, PARK7, HTT | CNR1 952/4885CNR2 1320/4885ALDH1A1 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.